Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical APIs. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113214267B reveals a novel one-step crystallization method for eszopiclone, offering high purity and significant cost reduction in pharmaceutical intermediates manufacturing.
Patent CN111482178A details a continuous fixed-bed process for chloroquine intermediates using supported nano-nickel, offering high purity and reduced environmental impact for reliable supply chains.
Discover the novel preparation method for Triamcinolone Acetonide via patent CN114478681A. Achieve higher yields, reduced wastewater, and superior purity for pharmaceutical manufacturing.
Advanced preparation method for Pitavastatin Calcium offering high yield and simplified purification for reliable API supply chains and cost-effective manufacturing.
Patent CN113372270A reveals a novel Lenvatinib preparation method eliminating genotoxic impurities. Discover cost reduction in API manufacturing and high-purity supply chain solutions.
Discover the advanced CN114853734A method for Nilotinib free base synthesis. Achieve higher purity and yield with optimized solvent systems for cost-effective manufacturing.
Novel high-boiling solvent method achieves >99.88% purity. Reduces energy consumption and wastewater compared to traditional water refining.
Advanced synthesis of (R)-9-(2-hydroxypropyl) adenine via selective acetylation. High-yield route for Tenofovir intermediates ensuring cost reduction and supply reliability.
Novel FeCl3-catalyzed reduction method for high-purity 2-aminopyrimidine compounds, eliminating toxic iron sludge and difficult impurities for scalable API manufacturing.
Novel mesylate salt formation improves purity and yield. Reduces dimer impurities. Ideal for scalable pharma manufacturing.
Patent CN113307744A reveals a high-purity oseltamivir phosphate method. Discover cost-effective manufacturing and supply chain advantages for antiviral APIs.
Advanced preparation of Desmopressin Acetate via solid-phase synthesis and liquid-phase oxidation. High purity, scalable process for reliable pharmaceutical intermediates supply.
Patent CN107428695B details a scalable Suzuki coupling for 2-chloro-4-(1H-pyrazol-3-yl)benzonitrile, reducing palladium usage and simplifying workup.
Patent CN108276338B details a green phenylbutazone method reducing wastewater and costs. Ideal for pharmaceutical API suppliers seeking efficient manufacturing.
Advanced synthesis of Tribenoside via CN112028950B eliminates genotoxic impurities. A cost-effective, high-purity route for API manufacturing supply chains.
Patent CN101712716B details a solid-phase iodine oxidation method for Vapreotide, improving yield and purity while simplifying manufacturing for reliable supply chains.
Patent CN102816211B details a high-yield Fmoc solid-phase synthesis for Afamelanotide, offering safer production and cost reduction in pharmaceutical manufacturing.
Patent CN108864057A details dual-target inhibitors for oncology. We offer scalable synthesis and cost reduction in pharmaceutical intermediates manufacturing for global partners.
Novel non-Friedel-Crafts route for Bromfenac Sodium. High purity, low waste, cost-effective manufacturing for global pharmaceutical supply chains.
Patent CN102267973B details a novel artemisinin intermediate synthesis using hydrogen peroxide, offering significant cost reduction and scalability advantages for pharmaceutical manufacturing.